Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) Interest & Investment Income (2024 - 2025)

Carlsmed (CARL) has disclosed Interest & Investment Income for 2 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income rose 150.73% year-over-year to $1.0 million, compared with a TTM value of $2.2 million through Dec 2025, changed N/A, and an annual FY2025 reading of $2.7 million, up 102.86% over the prior year.
  • Interest & Investment Income was $1.0 million for Q4 2025 at Carlsmed, up from $336000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.0 million in Q4 2025 and bottomed at $336000.0 in Q2 2025.